Acquisition of Reagents for Reproductive Medicine - Laboratory Media

This tender concerns the acquisition of reagents specifically for Reproductive Medicine, focusing on 'Laboratory Media'. Reproductive Medicine involves the diagnosis and treatment of infertility and other reproductive health issues. Laboratory media are essential substances used in fertility clinics and laboratories to support the growth, maintenance, and manipulation of cells, tissues, and gametes (sperm and eggs) during procedures like In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and embryo culture. These media are carefully formulated to provide the optimal biochemical environment for reproductive cells and embryos. The procurement aims to ensure that the laboratory performing these specialized procedures has access to high-quality, reliable media. The tender will detail the specific types of media required (e.g., fertilization media, culture media, cryopreservation media), their formulations, sterility requirements, performance standards, quantities, and delivery logistics. The quality of these reagents is paramount for the success rates of assisted reproductive technologies.

This is a supplies contract in the health and medical services, environment and climate and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1,814.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.